Search for: "WYETH PHARMACEUTICALS COMPANY" Results 181 - 200 of 547
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2011, 2:10 am by Bob Kraft
Nannery went on to say, “We are disappointed because the tort system is there to hold pharmaceutical companies accountable for vaccine design. [read post]
25 Feb 2011, 2:02 pm by Juliana
This sounds like a win-win situation, but some wonder if big pharmaceutical companies should be quite so sheltered from the market. [read post]
23 Feb 2011, 6:27 am by Lawrence B. Ebert
In 2010, with $10.8 billion in sales, Lipitor still accounted for 15.8% of total revenue, even with the addition of Wyeth's operations. [read post]
22 Feb 2011, 5:02 pm
 All of the lawsuits claim that the drug caused patients to develop breast cancer and that the company’s Wyeth unit failed to warn doctors and patients of the potential side effects of hormone replacement therapy. [read post]
20 Feb 2011, 9:21 pm
The lawsuit has named Pharmaceutical Associates Inc., its parent company Beach Products Inc. and Morton Grove Pharmaceuticals Inc. as defendants in the lawsuit. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
25 Jan 2011, 10:58 pm by Marie Louise
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
13 Jan 2011, 2:55 pm by Bexis
We put up an initial post about Bausch v. [read post]
7 Jan 2011, 11:41 am by Briggs
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
7 Jan 2011, 11:41 am by Briggs
The rationale behind passage of the Act was the fear that pharmaceutical companies would stop manufacturing vaccines if they were exposed to litigation for defective vaccines. [read post]
5 Jan 2011, 4:42 am by Sean Wajert
Super. 2003). , in which a New Jersey appeals court emphasized the difference between the pharmaceutical industry and other companies. [read post]
3 Jan 2011, 9:45 pm by Law Lady
Pharmaceuticals: GLAXO AND SUBSIDIARY SETTLE CIVIL, CRIMINAL CASES FOR $750 MILLION, United States v. [read post]
29 Dec 2010, 12:54 pm by Bexis
  In a transparent attempt to hamstring pharmaceutical marketing, the state of Vermont made it illegal for data miners to sell physician prescribing information to pharmaceutical companies. [read post]